" class="no-js "lang="en-US"> Optibrium - Medtech Alert
Tuesday, July 29, 2025
Optibrium | Pharmtech Focus

Optibrium

About Optibrium

Optibrium

Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s lead product, StarDrop™, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop™ enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. The company’s new Augmented Chemistry™ products and services deliver ground-breaking artificial intelligence technologies that continuously learn from all available data to supplement your experience and skills.

Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in Boston and San Francisco, USA. Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.

Related Story

Optibrium Appoints Steve Yemm as Chief Commercial Officer

January 17 2023

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]

Optibrium Appoints Ian Smith as Chief Technology Officer (CTO)

November 23 2022

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]

Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments

October 4 2022

Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]

Optibrium Receives Further Investment From Kester Capital

June 22 2022

Optibrium™, a developer of software for drug discovery, today announced it has secured further investment […]

Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park

June 9 2022

Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK […]

Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances

December 9 2021

Optibrium Limited, a leading provider of software and artificial intelligence (AI) solutions for drug discovery, […]